These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7545724)

  • 21. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
    Chalise PR; Agrawal CS
    Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of preoperative urodynamics to the prognosis of transurethral prostate resection for benign prostatic hyperplasia].
    Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
    Zhonghua Nan Ke Xue; 2005 Mar; 11(3):207-9. PubMed ID: 15804115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia with persistent symptoms following treatment with alpha1-adrenoceptor blocker].
    Naruoka T; Suzuki Y; Furuta A; Endo K; Sugaya S; Egawa S
    Hinyokika Kiyo; 2008 May; 54(5):341-4. PubMed ID: 18546857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a quality-of-life scale for Chinese patients with benign prostatic hyperplasia.
    Shi J; Sun Z; Cai T; Yang L
    BJU Int; 2004 Oct; 94(6):837-44. PubMed ID: 15476519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation between hypertension and clinical cases of benign prostatic hyperplasia].
    Nicolás Torralba JA; Tornero Ruiz J; Bañón Pérez V; Server Pastor G; López Cubillana P; Pérez Albacete M
    Arch Esp Urol; 2003 May; 56(4):355-8. PubMed ID: 12830607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
    Riehmann M; Jønler M; Nordling J; Hald T
    Ugeskr Laeger; 1996 May; 158(20):2853-8. PubMed ID: 8686021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
    Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
    J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia.
    Fu WJ; Hong BF; Wang XX; Yang Y; Cai W; Gao JP; Chen YF; Zhang CE
    Asian J Androl; 2006 May; 8(3):367-71. PubMed ID: 16625289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of the quality of life scale specific for patients with benign prostatic hyperplasia].
    Shi JC; Cai TS; Peng MN; Sun ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):28-31. PubMed ID: 15871183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
    Güler C; Tüzel E; Doğantekin E; Kiziltepe G
    Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benign prostatic hyperplasia and evidence based medicine: its approach in clinical practice].
    Carballido Rodríguez JA; Rodríguez Vallejo JM; del Llano Señaris JE
    Med Clin (Barc); 2000; 114 Suppl 2():96-104. PubMed ID: 10916816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
    Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O
    Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign prostatic hyperplasia in elderly Thai men in an urban community: the prevalence, natural history and health related behavior.
    Tantiwong A; Nuanyong C; Vanprapar N; Swasdipala P; Chittapraphai S
    J Med Assoc Thai; 2002 Mar; 85(3):356-60. PubMed ID: 12117026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery].
    Granados EA
    Arch Esp Urol; 1998 Sep; 51(7):675-9. PubMed ID: 9807893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.
    Djavan B; Roehrborn CG; Shariat S; Ghawidel K; Marberger M
    J Urol; 1999 Jan; 161(1):139-43. PubMed ID: 10037386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.